| 31.63 Real-Time Quote | -0.35 / -1.09%Today’s Change | 14.82 Today|||52-Week Range 33.04 | +70.79% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $4.3B |
Company Description
Alkermes Plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. The company was founded by Floyd E. Bloom in 1987 and is headquartered in Dublin, Ireland.
Employees

Shareholders
| Mutual fund holders | 63.40% |
| Other institutional | 32.95% |
| Individual stakeholders | 0.72% |
Top Executives
| Richard F. Pops | Chairman & Chief Executive Officer |
| Shane Cooke | President |
| Gordon G. Pugh, MBA | Chief Operating & Risk Officer |
| James M. Frates, MBA | Senior VP, Chief Financial & Accounting Officer |
| Elliot W. Ehrich, MD | Chief Medical Officer, SVP-Research & Development |